3-Iodo-1H-pyrazole-4-carbonitrile, 95.0%, 250mg

6-METHOXY-5-METHYL-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE, 95.0%, 1g

2-(3-Cyclopropyl-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 250mg

ETHYL 4-AMINO-1-METHYL-1H-IMIDAZOLE-2-CARBOXYLATE, 95.0%, 250mg

Obiettivo piano PLPHi 10x/0,25 contrasto di fase IOS corretto all'infinito

Silica gel 150, 250 g

Methyl 2-(2-fluoro-4-nitrophenyl)acetate, 95.0%, 5g

5-Bromo-2-fluoro-3-methoxypyridine, 95.0%, 25g

(R)-TERT-BUTYL 6-(AMINOMETHYL)-2,2-DIMETHYLMORPHOLINE-4-CARBOXYLATE, 95.0%, 250mg

Ethyl Chloroglyoxylate>98.0%(T)100g

endo-BCN-Fmoc-L-Lysine>95.0%(HPLC)25mg

Ethyl 3,5-Bis(trifluoromethyl)phenylacetate, 97.0%, 5g

4-Bromo-2-(trifluoromethyl)benzoic acid, 97.0%, 1g